Dr. Esranur Aydın

Precision Oncology Scientist (PhD)
Molecular Biologist & Geneticist

Her work focuses on clinical data curation, the definition of personalized treatment strategies, and genomic data analysis processes for Molecular Tumor Boards (MTBs). Within this scope, she carries out the clinical interpretation of comprehensive genomic profiles and the scientific curation, interpretation, and reporting of molecular biomarker data in the oncology context. By ensuring coordination among scientists, clinicians, and diagnostic teams, she aims to make multi-omic data clinically meaningful, optimize targeted treatment options, and identify resistance mechanisms.

The core goal of her work is to integrate precision oncology standards directly into clinical practice. To this end, she maintains dynamic collaborations with the world's leading genomic profiling companies, international consortia, and respected academic institutions at both national and global levels. These multi-partner translational research and scientific publication activities serve as a bridge for delivering the most current treatments to patients. She also carries out national and international training programs, contributing to the education and mentorship of fellow researchers.